Press Releases T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.84 ^USD	+3.65%		-4.05%	-54.74%

Apr. 23	Top Premarket Decliners	MT
Apr. 01	T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024	Apr. 24	AQ
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity	Apr. 11	AQ
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.	Mar. 28	AQ
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	Mar. 20	AQ
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates	Mar. 19	AQ
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel	Mar. 18	AQ
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement	Mar. 12	AQ
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results	Feb. 15	AQ
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity	Feb. 15	AQ
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia	Feb. 15	AQ
T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel	Feb. 12	AQ
T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024	Feb. 07	AQ
U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize	Feb. 07	AQ
T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients	Jan. 18	AQ
T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing	Jan. 03	AQ
T2 Biosystems: Q3 Earnings Snapshot	Nov. 15	AQ
T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum	Nov. 03	AQ
T2 Biosystems Regains Compliance with Nasdaq Listing Requirements	Nov. 01	AQ
T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference	23-10-24	AQ
T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement	23-10-23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Press Releases

Filters